These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 32656345)
41. Case of cannabinoid hyperemesis syndrome with long-term follow-up. Cha JM; Kozarek RA; Lin OS World J Clin Cases; 2014 Dec; 2(12):930-3. PubMed ID: 25516874 [TBL] [Abstract][Full Text] [Related]
42. Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use. Hermes-Laufer J; Del Puppo L; Inan I; Troillet FX; Kherad O Case Rep Gastrointest Med; 2016; 2016():2815901. PubMed ID: 27980870 [No Abstract] [Full Text] [Related]
43. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review. Sorensen CJ; DeSanto K; Borgelt L; Phillips KT; Monte AA J Med Toxicol; 2017 Mar; 13(1):71-87. PubMed ID: 28000146 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department. Kum V; Bell A; Fang W; VanWert E Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. McConachie SM; Caputo RA; Wilhelm SM; Kale-Pradhan PB Ann Pharmacother; 2019 Nov; 53(11):1145-1152. PubMed ID: 31104487 [No Abstract] [Full Text] [Related]
46. Cannabis hyperemesis syndrome: A case report review of treatment. Mahmad AI; Jehangir W; Littlefield JM; John S; Yousif A Toxicol Rep; 2015; 2():889-890. PubMed ID: 28962425 [TBL] [Abstract][Full Text] [Related]
47. TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids. Louis-Gray K; Tupal S; Premkumar LS Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077412 [TBL] [Abstract][Full Text] [Related]
48. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline. Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069 [TBL] [Abstract][Full Text] [Related]
49. Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome. Habboushe J; Sedor J Am J Emerg Med; 2014 Jun; 32(6):690.e1-2. PubMed ID: 24418446 [TBL] [Abstract][Full Text] [Related]
50. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent. Desjardins N; Jamoulle O; Taddeo D; Stheneur C J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366 [TBL] [Abstract][Full Text] [Related]
51. Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. Smith TN; Walsh A; Forest CP JAAPA; 2019 Apr; 32(4):1-5. PubMed ID: 30913155 [TBL] [Abstract][Full Text] [Related]
52. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Richards JR; Gordon BK; Danielson AR; Moulin AK Pharmacotherapy; 2017 Jun; 37(6):725-734. PubMed ID: 28370228 [TBL] [Abstract][Full Text] [Related]
53. Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic. Lu ML; Agito MD Cleve Clin J Med; 2015 Jul; 82(7):429-34. PubMed ID: 26185942 [TBL] [Abstract][Full Text] [Related]
54. Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome. Geraci E; Cake C; Mulieri KM; Fenn NE J Pediatr Pharmacol Ther; 2023; 28(3):222-227. PubMed ID: 37303765 [TBL] [Abstract][Full Text] [Related]
55. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]. Naver AV; Theede K Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240 [TBL] [Abstract][Full Text] [Related]
56. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome]. Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765 [TBL] [Abstract][Full Text] [Related]
57. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology. Iacopetti CL; Packer CD Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219 [TBL] [Abstract][Full Text] [Related]
59. Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms. Darmani NA Pharmaceuticals (Basel); 2010 Jul; 3(7):2163-2177. PubMed ID: 27713347 [TBL] [Abstract][Full Text] [Related]
60. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series. Graham J; Barberio M; Wang GS Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]